TW201028178A - Ganoderma extract with high amounts of ganoderic/lucidenic acids and method for producing the same - Google Patents
Ganoderma extract with high amounts of ganoderic/lucidenic acids and method for producing the same Download PDFInfo
- Publication number
- TW201028178A TW201028178A TW98102308A TW98102308A TW201028178A TW 201028178 A TW201028178 A TW 201028178A TW 98102308 A TW98102308 A TW 98102308A TW 98102308 A TW98102308 A TW 98102308A TW 201028178 A TW201028178 A TW 201028178A
- Authority
- TW
- Taiwan
- Prior art keywords
- ganoderma lucidum
- acid
- ganoderic
- ganoderma
- dried
- Prior art date
Links
- 229930182735 Ganoderic acid Natural products 0.000 title claims abstract description 30
- 239000000284 extract Substances 0.000 title claims abstract description 27
- 241000222336 Ganoderma Species 0.000 title claims abstract description 13
- 229930193921 lucidenic acid Natural products 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 240000008397 Ganoderma lucidum Species 0.000 claims description 106
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 106
- 238000000034 method Methods 0.000 claims description 46
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 claims description 40
- 239000000843 powder Substances 0.000 claims description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- 235000013399 edible fruits Nutrition 0.000 claims description 30
- 239000002253 acid Substances 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 24
- 239000000287 crude extract Substances 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 9
- 238000004811 liquid chromatography Methods 0.000 claims description 9
- -1 acanthoic acid compound Chemical class 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 238000003306 harvesting Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- TVHDZSRRHQKNEZ-UHFFFAOYSA-N (-) acanthoic acid Natural products OC(=O)C1(C)CCCC2(C)C3=CCC(C=C)(C)CC3CCC21 TVHDZSRRHQKNEZ-UHFFFAOYSA-N 0.000 claims description 2
- 150000003021 phthalic acid derivatives Chemical class 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims 1
- 229940125758 compound 15 Drugs 0.000 claims 1
- 239000013058 crude material Substances 0.000 claims 1
- 239000007791 liquid phase Substances 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- BSEYIQDDZBVTJY-UHFFFAOYSA-N Ganoderic acid A Natural products CC(CC(=O)CCC1CC(O)C2(C)C3=C(C(=O)CC12C)C4(C)CCC(=O)C(C)(C)C4CC3O)C(=O)O BSEYIQDDZBVTJY-UHFFFAOYSA-N 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- JGWQYLZHPPFHEH-HNXDABDESA-N (Z)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid Chemical compound CC(CC(=O)\C=C(\C)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(O)=O JGWQYLZHPPFHEH-HNXDABDESA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- VYQCXVOCHCSVIL-UHFFFAOYSA-N Ganoderenic acid D Natural products CC(C)CC(=O)C=C(/C)C1CC(=O)C2(C)C3=C(C(=O)CC12C)C4(C)CCC(=O)C(C)(C)C4CC3O VYQCXVOCHCSVIL-UHFFFAOYSA-N 0.000 description 1
- 239000005980 Gibberellic acid Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- OWPIQJAXQUDFDL-UHFFFAOYSA-N ganoderma aldehyde Natural products Oc1ccc2OC3(O)C(CCC(C(=C)C=O)C3=O)C(=O)c2c1 OWPIQJAXQUDFDL-UHFFFAOYSA-N 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- VZYPWBVGOUSGOD-KEUIGMMSSA-N lucidenic acid A Natural products COC(=O)CC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4C[C@@H]3O VZYPWBVGOUSGOD-KEUIGMMSSA-N 0.000 description 1
- INIPQDKLXQHEAJ-RGGGUVNYSA-N lucidenic acid a Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@H]1C[C@H](O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CCC(O)=O)C)CC(=O)[C@]21C INIPQDKLXQHEAJ-RGGGUVNYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
201028178 - 六、發明說明: 【發明所屬之技術領域】 本發明大致是關於一種製備乾燥靈芝粉末的方法,特別 是,關於-種製備具有高量靈芝酸/赤芝酸之乾燥靈芝粉束的方 【先前技術】 ❹ 食藥用真菌被廣泛做為保健食品,其中又以靈芝為大 宗γ—般所說的靈芝,泛指赤芝與紫芝兩種^依據分類學, 泰 UGanoderma lucidum)包含柃衫隻支{G_derma 等傘菌蓋呈紅褐色的靈芝。至於紫芝則以中國靈芝 (G.Slnense)為代表,其菌傘蓋呈紫黑色或深褐色。由於靈 . 芝含有多種活性成分,因此在東南亞地區,經常以靈芝子 實體入藥。這些活性成分包括靈芝三萜類、多醣體蛋白 質、核酸、多肽及植物固醇化合物等。靈芝三萜類是靈芝 最重要的活性成分,包括靈芝酸A、B、C、D、E、F、G 及Η,以及其他的靈芝醇、靈芝醛及羊毛固烷類化合物, 通稱為靈芝二搭類。迄今已有許多文獻陸續證明這些活性 成分具有抗腫瘤、增強免疫力(參見美國專利第4,〇51314 號、第6,613,754Β1號)及抗氧化等功效,因此也提出多種 可自靈芝子實體中萃取出這些活性成分的方法,最常見的 方式是以諸如水之類的極性溶劑來萃取採收後、新鮮的或 乾燥的靈芝原料。例如’中國發明專利申請號96116559 6 中揭不一種製備活性靈芝多醣與高量靈芝酸的方法,包含 將靈芝原料經破碎、水提取、過濾、濃縮後,製成欲求的 201028178 f狀物。據此專利說明書内文表示’其所揭示方法的提取 率約為40%,且相較於傳統製備方法,由此專力方法所提 取的靈芝多醣的藥理活性提高了約3〇〇〜5〇〇%,惟其並未 述及此方法對靈芝最重要活性成分-靈芝酸含量的提升效 率為何。 因此,返需一種改良的乾燥靈芝粉末之製備方法,其 不僅可達成高萃取率的目地,還可保存靈芝原料(即,子 實體)中最重要活性成分-靈芝酸/赤芝酸化合物,使乾燥靈 φ 芝粉末中含有至少50%(重量%)的靈芝酸/赤芝酸。 【發明内容】 本發明在此提供一種有高量靈芝三萜類活性成分(包括 靈芝酸/赤芝酸)之乾燥靈芝粉末,以及其之製備方法。 本發明方法特徵在於包含以下步驟: (a) 以一第一極性溶液來萃取一靈芝子實體粗萃物粉末; (b) 在一快速液相色層層析管柱中,以濃度介於 參 20%〜80°/。(體積°/。)間的一第二極性溶液,來提取步驟⑷所得萃 取液中的靈芝酸/赤芝酸類化合物;及 (c) 對步驟(b)所得沖提液施以冷凍乾燥,可得該乾燥靈芝 粉末》 在一實施方式中’該第一及第二極性溶液包含乙醇。 可用於本發明方法的靈芝子實體粗萃物粉末,較佳是以一 包含以下步驟的方法製備而成:(1)將採收後不超過4〜8小時 且未經乾燥處理的新鮮靈芝子實體或是採收後已乾燥並粉碎 201028178 的靈芝子實體浸泡在一極性溶液中約2〜16小時;(2)升高該内 含新鮮靈芝子實體之極性溶液的溫度至不超過約1 〇〇t,並攪 拌萃取約1〜4小時;及(3)對步驟(2)所得液體實施減壓濃縮及冷 凉·乾燥處理。在一較佳實施方式中,該靈芝包含松杉靈芝 (Ganodenna tsugae)氟赤芝(Gan〇derma iucidum)氟其之紕合,其 中又以採收後不超過4〜8小時,且未經乾燥處理過的新鮮松杉 靈芝或赤芝為佳。在一實例中,用於此方法步驟中的極性溶 液包含乙醇。在另一實例中,此方法的萃取率約達2〇0/〇(重量 %)’且所得靈芝子實體粗萃物中含有約2〜4%的靈芝酸類化合 物。 本發明方法步禪(b)更包含以下處理:(bi)以濃度介於 20~40。/。(體積%)之乙醇溶液進行一第一次沖提;及(b2)以濃度 介於50〜70〇/。(體積%)之乙醇溶液進行一第二次沖提。在一實例 中’該快速液相色層層析管柱包含C-18逆相色層層析管柱。 在一較佳實例中,本發明方法的萃取率約為1〇〜3〇%,且所得 乾燥$芝粉末中含有至少約5〇%的靈芝酸/赤芝酸類化合物,其 包含至少6種靈芝酸/赤芝酸化合物(包括GA、GB、GC、GN、 GD2及GE2)或是至少9種靈芝酸/赤芝酸化合物,該9種靈芝 酸/赤芝酸化合物包含靈芝酸A (Ga)、靈芝酸A之衍生物、靈 芝酸D (GD)及其之組合,且靈芝酸a之衍生物包括gb、GC、 GD、GE、GC5、GC6 和 GG。 本發明的另一目的在於提供一種以所述方法製備而成具 有高量靈芝酸/赤芝酸類化合物的乾燥靈芝粉末。在一實例中, 依據所述方法製備而成的乾燥靈芝粉末,含有至少約 50%(重量 %)的靈芝酸/赤芝酸類化合物。 201028178 【實施方式】 萃取出高 的乾燥萃 成 本 依據本發明,提供一種可自一食藥用真菌中 量活性化合物的方法,以及以此方法所製備而成 靈芝三@類活性 靈芝粉末的方法。 在本發明中’提供一種製備具高量 分(即,靈芝酸/赤芝酸類化合物)之乾燥 發明方法特徵在於: • (a)以一第一極性溶液來萃取一靈芝子實體粗萃物粉末. (b)在一快速液相色層層析管柱中, ' Λ,晨度介於 〜70%(體積%)間的一第二極性溶液,來提取步驟(a)所得萃 * 取液中的靈芝酸/赤芝酸類化合物;及 (c)對步驟(b)所得沖提液施以冷凍乾燥,可得該乾燥靈芝 粉末。 ’ 可以任何習知方式來製造可用於本發明方法的靈芝子實體 φ 粗萃物粉末。在一較佳實施方式中,該靈芝子實體粗萃物粉末 是以如下方式製成:首先,以一極性溶劑來對靈芝子實體進 行粗卒。在此所指的靈芝子實體包括新鮮靈芝的子實體, 特別是採收後不超過4小時,較佳是不超過5、6、7或8小 時且未經乾燥處理過的新鮮靈芝子實體;或是採收後、已乾 燥並經適當方式(包括’機械性研磨、切割或真空粉碎等)粉碎 的靈芝子實體。所述靈芝包括松杉靈芝(Gawderwa 或 赤芝(Gawoi/erwifl /wcz'dww)或其之組合。此粗萃步称一般分成 兩階段實施:首先,在室溫下,將上述靈芝子實體,完全 浸泡在一極性溶劑中至少約2、3、4、5、6、7、8、9、 201028178 1 液0的:二達13不1二15或16小時;接著,升高此浸泡 ΐ = 7二f ?的溫度,較佳是不超過9〇 n ^ oc或50c,最佳是約50°c的溫度, 同時授拌此浸泡液至少約1、2、3々 的^ I蛀 A人t 3或4小時,最佳是至少 二:二 性溶劑實例包括(但不限於)水及醇 類’例如乙醇、丙醇、異丙醇、正-丁醇、異-丁醇等。在 萃取步驟之後,可以任何適當 、 ^ ^ ^ ^ ^ 收集液體(即,萃出液),並將201028178 - VI. Description of the invention: [Technical field of the invention] The present invention generally relates to a method for preparing a dried ganoderma lucidum powder, in particular, a method for preparing a dried ganoderma lucidum powder bundle having a high amount of ganoderic acid/anthuric acid. Prior art ❹ medicinal fungi are widely used as health foods, among which Ganoderma lucidum is a large gamma-like ganoderma lucidum, which refers to both Ganoderma lucidum and Ganoderma lucidum. According to taxonomy, UGanoderma lucidum contains only vestibules. {G_derma and other agaric caps are reddish brown Ganoderma lucidum. As for Zizhi, it is represented by G.Slnense, and its umbrella cover is purple-black or dark brown. Because Lingzhi contains a variety of active ingredients, it is often used in South East Asia as a medicine for Ganoderma lucidum. These active ingredients include ganoderma triterpenoids, polysaccharide proteins, nucleic acids, polypeptides, and phytosterol compounds. Ganoderma lucidum triterpenoids are the most important active ingredients of Ganoderma lucidum, including Ganoderma lucidum A, B, C, D, E, F, G and strontium, as well as other Ganoderma lucidum, Ganoderma aldehyde and lanosterane compounds. Take the class. A number of literatures have been published to date to prove that these active ingredients have anti-tumor and immunity (see U.S. Patent No. 4, No. 51,314, No. 6,613,754, No. 1) and antioxidant effects, and therefore various extracts from Ganoderma lucidum fruit bodies have also been proposed. The most common way to extract these active ingredients is to extract the harvested, fresh or dried Ganoderma lucidum raw material using a polar solvent such as water. For example, the Chinese Patent Application No. 96116559 6 discloses a method for preparing an active ganoderma lucidum polysaccharide and a high amount of ganoderic acid, which comprises crushing, water extracting, filtering and concentrating the ganoderma lucidum raw material to prepare a desired 201028178 f. According to the specification of the patent specification, the extraction rate of the method disclosed therein is about 40%, and the pharmacological activity of the Ganoderma lucidum polysaccharide extracted by the special method is improved by about 3〇〇~5〇 compared with the conventional preparation method. 〇%, but it does not mention the efficiency of this method for improving the content of Ganoderma lucidum, the most important active ingredient of Ganoderma lucidum. Therefore, there is a need for an improved method for preparing a dried ganoderma lucidum powder which not only achieves a high extraction rate but also preserves the most important active ingredient in the raw material of the ganoderma lucidum (ie, fruit body) - a ganoderic acid/anthoic acid compound to dry Ganoderma lucidum powder contains at least 50% by weight of ganoderic acid/erythric acid. SUMMARY OF THE INVENTION The present invention provides a dried ganoderma lucidum powder having a high amount of Ganoderma lucidum triterpenoid active ingredients (including ganoderic acid/erythric acid), and a preparation method thereof. The method of the present invention is characterized by comprising the steps of: (a) extracting a crude extract of a ganoderma lucidum fruit body with a first polar solution; (b) in a fast liquid chromatography chromatography column at a concentration of 20%~80°/. a second polar solution (volume ° /.) to extract the ganoderic acid / gibberellic acid compound in the extract obtained in the step (4); and (c) subjecting the extract obtained in the step (b) to freeze-drying, The dried ganoderma powder "In one embodiment, the first and second polar solutions comprise ethanol. The crude extract of Ganoderma lucidum fruit body which can be used in the method of the present invention is preferably prepared by a method comprising the following steps: (1) fresh ganoderma lucidum which will not be dried for more than 4 to 8 hours after harvesting The body or the Ganoderma lucidum fruit body which has been dried and pulverized after harvesting is immersed in a polar solution for about 2 to 16 hours; (2) the temperature of the polar solution containing the fresh Ganoderma lucidum fruit body is raised to not more than about 1 〇 〇t, and stirring for about 1 to 4 hours; and (3) subjecting the liquid obtained in the step (2) to concentration under reduced pressure and cooling and drying. In a preferred embodiment, the ganoderma lucidum comprises a combination of Ganodder tsugae and genus Ganoderma lucidum, which is not more than 4 to 8 hours after harvesting, and is not dried. Fresh pine yew or Ganoderma lucidum is preferred. In one example, the polar solution used in this method step comprises ethanol. In another example, the extraction rate of the process is about 2 〇 0 / 〇 (% by weight) and the resulting crude extract of Ganoderma lucidum fruit body contains about 2 to 4% of a Ganoderma lucidum compound. The method step (b) of the present invention further comprises the following treatment: (bi) at a concentration of between 20 and 40. /. (% by volume) of the ethanol solution is subjected to a first flushing; and (b2) is at a concentration of 50 to 70 Å/. The (vol%) ethanol solution was subjected to a second flush. In one example, the fast liquid chromatography column comprises a C-18 reverse phase chromatography column. In a preferred embodiment, the extraction rate of the method of the present invention is about 1 〇 to 3 〇%, and the resulting dried $zhi powder contains at least about 5% by weight of a ganoderic acid/anthoic acid compound comprising at least 6 ganoderic acid. / 芝ic acid compounds (including GA, GB, GC, GN, GD2, and GE2) or at least 9 ganoderic acid/anthodic acid compounds containing ganoderic acid A (Ga), ganoderic acid A Derivatives, Ganoderma D (GD) and combinations thereof, and derivatives of Ganoderma acid a include gb, GC, GD, GE, GC5, GC6 and GG. Another object of the present invention is to provide a dried ganoderma lucidum powder prepared by the method and having a high amount of a ganoderic acid/anthoic acid compound. In one example, the dried ganoderma lucidum powder prepared according to the method contains at least about 50% by weight of a ganoderic acid/anthoic acid compound. 201028178 [Embodiment] Extraction of high dry extracts According to the present invention, there is provided a method for recognizing an active compound from a medicinal fungus, and a method for preparing a Ganoderma lucidum three-type active ganoderma lucidum powder by the method. In the present invention, a method for preparing a dry invention having a high content (i.e., a ganoderma acid/anthoic acid compound) is provided, which is characterized in that: • (a) extracting a crude extract powder of a ganoderma lucidum fruit body with a first polar solution. (b) in a fast liquid chromatography column, 'Λ, a second polarity solution between ~70% (% by volume) in the morning to extract the extract from step (a) The ganoderma acid/acanthoic acid compound; and (c) the freeze-dried extract of the extract obtained in the step (b) to obtain the dried ganoderma lucidum powder. The Ganoderma lucidum fruiting body φ crude extract powder which can be used in the method of the present invention can be produced in any conventional manner. In a preferred embodiment, the Ganoderma lucidum fruit body crude extract powder is prepared in the following manner: First, the Ganoderma lucidum fruit body is subjected to a rough stroke with a polar solvent. The Ganoderma lucidum fruiting body referred to herein includes the fruiting body of fresh Ganoderma lucidum, especially fresh Ganoderma lucidum fruiting bodies which are not more than 4 hours after harvesting, preferably no more than 5, 6, 7 or 8 hours and have not been dried; Or a Ganoderma lucidum fruiting body that has been harvested, dried, and comminuted in a suitable manner (including 'mechanical grinding, cutting, vacuum pulverization, etc.). The ganoderma lucidum includes Gawderwa or Gawoi/erwifl /wcz'dww or a combination thereof. The crude extraction step is generally carried out in two stages: first, at room temperature, the above-mentioned Ganoderma lucidum fruit body is completely Soak in a polar solvent at least about 2, 3, 4, 5, 6, 7, 8, 9, 201028178 1 liquid 0: two up to 13 not 1 2 15 or 16 hours; then, raise this soak ΐ = 7 The temperature of the second f?, preferably not more than 9 〇 n ^ oc or 50 c, is preferably about 50 ° C, and the mixing of the soaking liquid is at least about 1, 2, 3 ^. 3 or 4 hours, optimally at least two: examples of the dibasic solvent include, but are not limited to, water and alcohols such as ethanol, propanol, isopropanol, n-butanol, iso-butanol, etc. in the extraction step After that, the liquid (ie, the extract) can be collected at any appropriate ^ ^ ^ ^ ^
及乾燥。可以任何習知的方式來執行此漠縮及乾燥 &實例中’係在-減壓環境下,例如壓力約 環境下,將萃出液濃縮,待萃出液中的固形物 3量達20/。^,即停止此濃縮處理。接著,將濃縮物乾燥, J如在30 C〜-5 0C下冷;東乾燥。依據本發明方法,可 獲得靈芝子實體粗萃物粉末,其中包含靈芝酸/赤芝酸在 内之靈芝三萜類含量約在2〜4%之間。 在實施本發明方法時,首先在一容器中,將適量之以 上述方式製備而成的靈芝子實體粗萃物粉末,與一第一極 陡/合液混合,混合時係以粉末重量:極性溶液體積約為1 : 10至1·30的比例混合。舉例來說,i公斤的靈芝子實體 粗萃物粉末可與約1 〇公升〜3 〇公升的第一極性溶液混 β。適用於此步釋的第一極性溶液包含(但不限於)水及醇 類’例如乙醇、丙醇、異丙醇、正丁醇、異-丁酵等。在 實例中’此第一極性溶液為5〇%(體積%)的乙醇。接著, 將現合物在不超過1〇〇〇c的溫度,較佳是不超過9〇e>c、8〇 C、70°C、60°C或50°C,最佳是約50°C的溫度下,攪拌 至少約30、40、50、60、70、80或90分鐘,最佳是至少 7 201028178 . 約6〇分鐘。之後,以過濾或離心方式除去殘渣,並收集 渡液’並將濾液濃縮直到呈現膠狀為止。可以任何習知的 方式來執行此濃縮步驟。接著,在此膠狀物中,逐次加入 適量的第一極性溶液,將此膠狀物回溶,直到完全溶解為 止。接著,利用快速液相色層層析法(flas c〇lumn chromatography)來分離此回溶液中的各種靈芝活性成分。操 作時,首先將此回溶的膠狀液载入至快速液相色層層析管 柱中;接著,在約80〜180毫升/分鐘的流速下(較佳是約8〇、9〇、 ❹ 100、110、120、130、140、150、160、170 或 18〇 毫升/分鐘, 更佳是約100、110、120、130、140或150毫升/分鐘;),以濃 度在 20%〜70%間(較佳是 20%、30%、35%、40%、450/。、50%、 55% ' 60% ' 65%、7〇%、75%或 8〇%,更佳是約 35%、4〇%、 45%、50%、55%、6〇%、65%或7〇%)的第二極性溶液進行沖提, 並收集所得沖提液。在一實例中,此快速液相色層層析管柱為 C 18逆相色層層析管柱。在另一實例中,此沖提處理可分成兩 階段進行.首先,在約1〇〇毫升/分鐘的流速下,以約2〇〜4〇β/。(體 © 積/(>)之乙醇溶液進行第一次沖提;接著,以濃度介於50〜70%(體 積%)之乙醇溶液進行第二次沖提。將兩次沖提後的沖提液收集 在一起’並經減壓濃縮及冷凍乾燥後,可獲得欲求的靈芝 酸乾燥粉末,產率約在1〇〜3〇%間。可以任何習知的方式 來執行此濃縮及乾燥的步驟。在一實例中,係在一減壓環 境下,例如壓力約〇· i t〇rr的環境下,將沖提液濃縮,待 冲提液中的固形物含量達2〇%時,即停止此濃縮處理。接 著,將濃縮物乾燥,例如,在_3〇*>C〜_5〇〇C下冷凍乾燥。 依據本發明方法,可獲得乾燥靈芝粉末’其中包含靈芝酸 8 201028178 • /赤芝酸在内之靈芝三萜類含量高達至少約50% (重量)。 因此,本發明也提供一種依據所述本發明方法製備而 成的乾燦靈芝粉末,且其中赤芝酸/靈芝酸的總含量高達至 少約50%(重量%)。在一較佳實施方式中,所製得的乾燥 靈芝粉末中包含至少5〇%(重量%)之9種靈芝酸化合物,該 9種靈芝酸7赤芝酸化合物包含靈芝酸A(GA)、靈芝酸A之衍 生物、靈芝酸D (GD)及其之組合,且靈芝酸A之衍生物包括 GB、GC、GD、GE、GC5、GC6和GG。在另一較佳實施方式 中,所製得的乾燥靈芝粉末中包含至少51%(重量%)之ό種 赤芝酸化合物,包括GA、gb、GC、GN、GD2及GE2。 以下’將透過實施例來闡述本發明的較佳實施方式。 實施例1製備靈芝子實體粗萃物粉末 ———板杉黧芝:萃物狢市 參 採收新鮮且菌傘在10公分以内的松杉靈芝子實體 (菌種名.ΥΚ-01,約 J000 公斤將 其置入大型萃取槽中,並加入適量之95%酒精至萃取槽 中,直到靈芝子實體被完全浸沒在酒精溶液中為止❶室溫 下浸泡,夜’、約16小時。加熱混合物,使溶液溫度升高 至約5G°C ’並以30 rpm的速率挽拌萃取3小時。萃取液 以泵浦抽入真空濃縮槽中,於65〇 ,45<)匸下減壓濃 縮並回收酒精。當固形物(solid content)含量 2〇%〜25%時,停止濃縮。取出濃縮液,在_30°C〜-5〇V 之低溫下凍結成固體。高真〜o.i t叫冷凍乾燥48 小時後,可得黃棕色粉末45公斤,產率4 5%。 9 201028178 依據高效能液態色層分析法(HPLC)(J. Chin. Chem. Soc. 1999 46:47-51)分析可知,產物之總三萜類含量為 20%,且依據習知方法(J_ Food Drug Anal· 2003 1 1:195-200)測量包括靈芝酸A、靈芝酸A之衍生物(包括 GB、GC、GD、GE、GC5、GC6和GG)、靈芝酸D及其之組合 所組成之群組中共九種靈芝酸的含量,發現此九種靈芝酸 之含量約2%。所述方法的分析結果示於第1圖之高效液 相色層層析(high performance liquid chromatography, HPLC)圖表中。上述九種靈芝酸結構如下圖And dry. The condensation and drying can be carried out in any conventional manner. In the example, the extract is concentrated under a reduced pressure environment, such as a pressure environment, and the amount of solids 3 in the extract is up to 20 /. ^, that is, stop this concentration process. Next, the concentrate is dried, and J is cooled at 30 C to -5 0 C; According to the method of the present invention, a crude extract powder of Ganoderma lucidum fruit body can be obtained, wherein the Ganoderma lucidum triterpenoid content containing ganoderic acid/erythric acid is between about 2% and 4%. In the practice of the method of the present invention, firstly, an appropriate amount of the crude extract powder of Ganoderma lucidum fruit body prepared in the above manner is mixed with a first pole steep/liquid mixture in a container, and the powder weight: polarity is mixed. The solution volume is mixed in a ratio of about 1:10 to 1.30. For example, an i kilogram of Ganoderma lucidum fruiting body crude extract powder can be mixed with a first polar solution of about 1 liter liter to 3 liters liter. The first polar solution suitable for use in this step includes, but is not limited to, water and alcohols such as ethanol, propanol, isopropanol, n-butanol, iso-butyrate, and the like. In the example, this first polar solution is 5% by volume of ethanol. Next, the present compound is at a temperature of not more than 1 〇〇〇c, preferably not more than 9 〇e > c, 8 〇 C, 70 ° C, 60 ° C or 50 ° C, preferably about 50 °. Stir at a temperature of C for at least about 30, 40, 50, 60, 70, 80 or 90 minutes, preferably at least 7 201028178. About 6 minutes. Thereafter, the residue was removed by filtration or centrifugation, and the liquid was collected and the filtrate was concentrated until it was gelatinous. This concentration step can be performed in any conventional manner. Next, an appropriate amount of the first polar solution was successively added to the gel, and the gel was dissolved back until it was completely dissolved. Next, each of the active components of the ganoderma lucidum in the solution was separated by rapid liquid chromatography (flas c〇lumn chromatography). In operation, the remelted colloidal solution is first loaded into a fast liquid chromatography column; then, at a flow rate of about 80 to 180 ml/min (preferably about 8 Torr, 9 Torr, ❹ 100, 110, 120, 130, 140, 150, 160, 170 or 18 〇 ml / min, more preferably about 100, 110, 120, 130, 140 or 150 ml / min ;), to a concentration of 20% ~ 70% (preferably 20%, 30%, 35%, 40%, 450/., 50%, 55% '60% ' 65%, 7〇%, 75% or 8〇%, more preferably about 35%, 4%, 45%, 50%, 55%, 6%, 65% or 7% of the second polar solution is rinsed and the resulting extract is collected. In one example, the fast liquid chromatography column is a C 18 reverse phase chromatography column. In another example, the stripping treatment can be carried out in two stages. First, at a flow rate of about 1 〇〇 ml/min, about 2 〇 4 4 〇 β /. The first extraction is carried out in an ethanol solution of (products/(>); then, the second extraction is carried out in an ethanol solution having a concentration of 50 to 70% by volume. The extracts are collected together and concentrated under reduced pressure and lyophilized to obtain the desired dry powder of ganoderic acid in a yield of about 1 〇 to 3 〇%. This concentration and drying can be carried out in any conventional manner. In one example, the extract is concentrated under a reduced pressure environment, for example, under a pressure of about 〇·〇〇rr, and the solid content in the extract is up to 2%, ie The concentration treatment is stopped. Next, the concentrate is dried, for example, lyophilized at _3 〇 * > C 〜 5 〇〇 C. According to the method of the present invention, dried ganoderma lucidum powder can be obtained which contains ganoderic acid 8 201028178 • / The content of the triterpenoids of Ganoderma lucidum is at least about 50% by weight. Therefore, the present invention also provides a dry Ganoderma lucidum powder prepared according to the method of the present invention, and wherein the total amount of cinnamic acid/Ganoderma lucidum is The content is up to at least about 50% by weight. In a preferred embodiment The dried ganoderma lucidum powder obtained contains at least 5% by weight of 9 kinds of ganoderic acid compounds, and the 9 ganoderic acid 7 zhizhi acid compounds comprise ganoderic acid A (GA), a derivative of ganoderic acid A, and ganoderma lucidum Acid D (GD) and combinations thereof, and derivatives of Ganoderma A include GB, GC, GD, GE, GC5, GC6 and GG. In another preferred embodiment, the dried Ganoderma lucidum powder is contained At least 51% by weight of the erythroic acid compound, including GA, gb, GC, GN, GD2, and GE2. Hereinafter, preferred embodiments of the present invention will be described by way of examples. Example 1 Preparation of Ganoderma lucidum Fruiting Body Crude extract powder - 板 黧 黧 :: extract 狢 狢 参 参 且 且 且 且 且 且 且 且 且 且 且 且 且 且 且 且 且 且 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子 子In the extraction tank, add an appropriate amount of 95% alcohol to the extraction tank until the ganoderma lucidum fruit body is completely immersed in the alcohol solution, soak it at room temperature for about 16 hours. Heat the mixture to raise the temperature of the solution to About 5G ° C ' and extract at a rate of 30 rpm for 3 hours. The extract is pumped Drain into a vacuum concentration tank, concentrate at 65 〇, 45 lt 匸 under reduced pressure and recover alcohol. When the solid content is 2〇%~25%, the concentration is stopped. The concentrate is taken out at _30°. C~-5〇V freezes to a solid at low temperature. After high temperature~oi t called freeze-drying for 48 hours, it can obtain 45 kg of yellow-brown powder with a yield of 45%. 9 201028178 According to high performance liquid chromatography method ( HPLC) (J. Chin. Chem. Soc. 1999 46: 47-51) analysis shows that the total triterpenoid content of the product is 20%, and according to the conventional method (J_Food Drug Anal· 2003 1 1:195-200) The measurement includes a total of nine kinds of ganoderic acid in a group consisting of a derivative of Ganoderma lucidum A, a derivative of Ganoderma lucidum A (including GB, GC, GD, GE, GC5, GC6, and GG), Ganoderma lucidum D, and combinations thereof. The content of these nine kinds of Ganoderma lucidum was found to be about 2%. The results of the analysis of the method are shown in the high performance liquid chromatography (HPLC) chart of Figure 1. The above nine kinds of Ganoderma lucidum acid structure are as follows
R! Rj R3 R4 GA 0 α-Η,β-ΟΗ α-ΟΗ,β-Η Η GB α-Η,β-ΟΗ α-Η,β-ΟΗ Ο ΗR! Rj R3 R4 GA 0 α-Η,β-ΟΗ α-ΟΗ,β-Η Η GB α-Η,β-ΟΗ α-Η,β-ΟΗ Ο Η
GC α-Η,β-ΟΗ α-Η,β-ΟΗ α-ΟΗ,β-Η Η GD Ο α-Η,β-ΟΗ Ο Η GE Ο Ο Ο Η GC5 Ο α-ΟΗ,β-Η Ο ΟΗ GC6 α-Η,β-ΟΗ Ο Ο ΟΗ GG α-Η,β-ΟΗ α-ΟΗ,β-Η Η ΟΗGC α-Η,β-ΟΗ α-Η,β-ΟΗ α-ΟΗ,β-Η GD GD Ο α-Η,β-ΟΗ Η Η GE Ο Ο Η Η GC5 Ο α-ΟΗ,β-Η Ο ΟΗ GC6 α-Η,β-ΟΗ Ο ΟΗ GG GG α-Η,β-ΟΗ α-ΟΗ,β-Η Η ΟΗ
GA: Ganoderic acid AGA: Ganoderic acid A
Ganoderenic acid DGanoderenic acid D
Structures of nine ganoderic acids 1.2 赤芝子實體(YK-02)fe萃物粉東 除了以赤芝子實體(YK-02)(菌種名:YK-02, 10 201028178 /wcWwm)來取代松杉靈芝子實體(菌種名: YK-01,iwgae)之外,大致依照上述實施例i ^ 所述方法’製備赤芝子實體(YK-02)粗萃物。所得粗萃物 的HPLC圖譜示於第3圖十,其中含有六種赤芝酸化合物 (包括 GA、GB、GC、GN、GD2 及 GE2),含量約為 4%, 其化學結構如下圖所示:Structures of nine ganoderic acids 1.2 Ganoderma lucidum fruit body (YK-02) fe extract powder East in addition to the Ganoderma lucidum fruit body (YK-02) (strain name: YK-02, 10 201028178 / wcWwm) to replace the pine sage In addition to the strain name: YK-01, iwgae, the crude extract of the Ganoderma lucidum fruit body (YK-02) was prepared in accordance with the method described in the above Example i^. The HPLC chromatogram of the obtained crude extract is shown in Fig. 3, which contains six kinds of erythric acid compounds (including GA, GB, GC, GN, GD2 and GE2) in an amount of about 4%, and its chemical structure is shown in the following figure:
Structures of the six lucidenic acids. LA = Lucidenic acid A 實施例2 製備乾燥靈芝粉末 _尽實施例1.1之靈芝子實體(YK-01)粗萃物舲本盔庖 赴所製成的乾燥靈芝粉東 在一容器中’將100公克依據實施例1之方法製成 的靈芝子實體粗萃物與1公升的乙醇(濃度50%(體積%)) 混合,於50°C下攪拌約60分鐘》將混合物過濾(或是離 心),移除其中的固體’濾液經減壓濃縮後形成膠狀。在 此膠狀液中加入500毫升乙醇將其回溶,接著,將回溶液 載入至快速液相色層層析管柱(即,C-18逆相色層層析管柱) 中’先以流速約100毫升/分鐘之35%的乙醇溶液進行沖提,接 11 201028178 . 著再以流速約150毫升/分鐘之70%的乙醇溶液繼續進行沖提, 收集兩次沖提後的沖提液,約3公升。將所收集的沖提液濃縮、 冷凍乾燥後,可獲得約15.6公克的淡黃色粉末。經HPLC分析 後(示於第2圖),可發現原先存在於實施例1.1之靈芝子實體 粗萃物HPLC光譜(即,第1圖)中前端的極性訊號已消失,留 下大部分的靈芝酸類化合物,共9種,其結構如以上實施 例1.1中所示且總含量高達50.2%。 H以實施例1.2之赤芝子實體(YK-02)組萃物粉東為坪料 • 度製成的乾燥靈芝粉東 以實施例1.2之赤芝子實體(YK-02)粗萃物為原料, 大致依照實施例2.1所述方式,製備乾燥靈芝粉末。在實 施快速液相色層層析管枉後’同樣可得約3公升的沖提液, 將所收集的沖提液濃縮、冷凍乾燥後,可獲得約13.6公克的淡 黃色粉末。經HPLC分析後(示於第4圖),可發現原先存在於 實施例1.2之赤芝子實鳢粗萃物HPLC光譜(即,第3圖)中前 端的極性訊號已消失,留下大部分的赤芝酸類化合物,共6 藝種’其結構如以上實施例1.2中所示,且總含量高達 5 1 · 2 % 〇 雖然本發明已以一較佳實施例揭露如上,然其並非用以限 定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍 内,當可作各種之更動與潤飾,因此本發明之保護範圍當視後 附之申請專利範圍所界定者為準。 【圖式簡單說明】 12 201028178 ^ 第1圖為依據本發明實施例I·1之靈芝子實體粗萃物 的HPLC光譜圖; 第2圖為以實施例I1之靈芝子實體粗萃物為原料, 依據本發明實施例2.1所述方式而製得之乾燥靈芝粉末的 HPLC光譜圖; 第3圖為依據本發明實施例1·2之赤芝子實體粗萃物 的HPLC光譜圖;及 第4圖為以實施例1,2之靈芝子實體粗萃物為原料, ❶依據本發明實施例2.2㈣方“製得之乾燥靈芝粉末的 HPLC光譜圖。 【主要元件符號說明】LA = Lucidenic acid A Example 2 Preparation of dried Ganoderma lucidum powder _ The crude extract of Ganoderma lucidum fruit body (YK-01) as in Example 1.1 In a container, 100 g of the crude extract of Ganoderma lucidum fruit body prepared according to the method of Example 1 was mixed with 1 liter of ethanol (concentration: 50% by volume), and stirred at 50 ° C for about 60 minutes. Filtration (or centrifugation), removal of the solids in the filtrate was concentrated under reduced pressure to form a gel. The solution was reconstituted by adding 500 ml of ethanol to the colloidal solution, and then the solution was loaded into a fast liquid chromatography column (ie, a C-18 reverse phase chromatography column). The solution was eluted with a 35% ethanol solution at a flow rate of about 100 ml/min, followed by 11 201028178. The extraction was continued with a 70% ethanol solution at a flow rate of about 150 ml/min, and the two rinses were collected. Liquid, about 3 liters. After the collected extract was concentrated and lyophilized, about 15.6 g of a pale yellow powder was obtained. After HPLC analysis (shown in Figure 2), it was found that the polar signal of the front end of the crude extract of the Ganoderma lucidum fruit extract of Example 1.1 (ie, Figure 1) had disappeared, leaving most of the Ganoderma lucidum. There are 9 kinds of acid compounds, and the structure thereof is as shown in the above Example 1.1 and the total content is as high as 50.2%. H is the dried Ganoderma lucidum powder prepared from the extract of the Ganoderma lucidum fruit body (YK-02) group of Example 1.2, and the crude extract of Ganoderma lucidum (YK-02) of Example 1.2 is used as the raw material. Dry Ganoderma lucidum powder was prepared in substantially the manner described in Example 2.1. Approximately 3 liters of the extract was also obtained after the implementation of the rapid liquid chromatography chromatography, and the collected extract was concentrated and lyophilized to obtain about 13.6 g of a pale yellow powder. After HPLC analysis (shown in Figure 4), it was found that the polar signal of the front end of the crude extract of the genus Ganoderma lucidum which was originally present in Example 1.2 (i.e., Figure 3) had disappeared, leaving most of the A total of 6 phthalic acid compounds, the structure of which is as shown in the above Example 1.2, and the total content is as high as 5 1 · 2 %. Although the present invention has been disclosed above in a preferred embodiment, it is not intended to limit the present invention. The invention is to be understood as being limited by the scope of the appended claims. BRIEF DESCRIPTION OF THE DRAWINGS 12 201028178 ^ Fig. 1 is an HPLC spectrum of a crude extract of Ganoderma lucidum fruit body according to Example I of the present invention; Fig. 2 is a raw material of the crude extract of Ganoderma lucidum fruit body of Example I1. HPLC spectrum of dried Ganoderma lucidum powder prepared according to the method described in Example 2.1 of the present invention; FIG. 3 is an HPLC spectrum of the crude extract of Ganoderma lucidum fruit body according to Example 1 of the present invention; and FIG. For the crude extract of the Ganoderma lucidum fruit body of Example 1, 2, the HPLC spectrum of the dried Ganoderma lucidum powder prepared according to Example 2.2 (4) of the present invention. [Explanation of main component symbols]
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW098102308A TWI369998B (en) | 2009-01-21 | 2009-01-21 | Ganoderma extract with high amounts of ganoderic/lucidenic acids and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW098102308A TWI369998B (en) | 2009-01-21 | 2009-01-21 | Ganoderma extract with high amounts of ganoderic/lucidenic acids and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201028178A true TW201028178A (en) | 2010-08-01 |
TWI369998B TWI369998B (en) | 2012-08-11 |
Family
ID=44853445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW098102308A TWI369998B (en) | 2009-01-21 | 2009-01-21 | Ganoderma extract with high amounts of ganoderic/lucidenic acids and method for producing the same |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI369998B (en) |
-
2009
- 2009-01-21 TW TW098102308A patent/TWI369998B/en active
Also Published As
Publication number | Publication date |
---|---|
TWI369998B (en) | 2012-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110317156B (en) | A deep eutectic solvent microemulsion extraction system and method for extracting astaxanthin | |
CN103351941A (en) | Supercritical CO2 variable-temperature variable-pressure extraction method of lucid ganoderma spore oil | |
CS219880B2 (en) | Method of isolation of the polysaccharide | |
JP5597136B2 (en) | Method for producing composition containing high sapogenin | |
JP2011026525A (en) | METHOD FOR EXTRACTING POLYSACCHARIDE COMPRISING beta-GLUCAN AS MAIN COMPONENT | |
CN1947732A (en) | Extraction method for primary active matter of edible fungi | |
KR20110090415A (en) | Method for preparing highly concentrated maca extract and composition thereof | |
DK145424B (en) | PROCEDURE FOR MANUFACTURING NITROGEN CONTAINING POLYSACCHARIDES WITH ANTI-TUMOR-EFFECTIVE | |
JP2011236183A (en) | Method for extracting ergosterol peroxide derived from mushrooms | |
KR20110112580A (en) | Process for preparing water soluble propolis | |
TW201028178A (en) | Ganoderma extract with high amounts of ganoderic/lucidenic acids and method for producing the same | |
JP2005068114A (en) | Pleurotus cornucopiae fruit body composition, method for producing the same, and immunopotentiator, anticancer agent and food product | |
TW201124149A (en) | A method for isolating ganoderic acids from Ganoderma growth bags | |
CN110144017B (en) | A kind of continuous preparation technology of active ingredients in spores of Bamboo fungus | |
KR101502798B1 (en) | Hepatic Fibrosis Cure Composition containing Methanol Extracts from Rhus Chinensis and Method for Producing the same | |
KR101938348B1 (en) | Method for separating fattic acid oil and water-soluble peptide from grub | |
KR100559263B1 (en) | Method for preparing ergosterol epoxide and physiologically acceptable salts thereof from shiitake mushrooms | |
TWI476014B (en) | Ganoderma extract with high amount of ganoderic acids and method for producing the same | |
JP2002029992A (en) | Activity accelerator for active oxygen scavenging enzyme | |
KR20220076576A (en) | Method for separating water-soluble extract and fat-soluble extract containing betaglucan from mushroom | |
CN101380341B (en) | Preparation method of compound propolis preparation | |
JP4480204B2 (en) | Anti-tumor fraction of Kawariharatake | |
KR102494672B1 (en) | Method for preparing compound K using red ginseng, enzymes and natural products | |
JPH05117304A (en) | Water-soluble polysaccharide originating from yamabushitake (fungus) and antitumor agent mainly containing the same | |
WO2019014037A1 (en) | Method for treating alcoholic hepatitis |